Combinatorial assessment of ctDNA release and mutational burden predicts anti-PD(L)1 therapy outcome in nonsmall-cell lung cancer

CLINICAL AND TRANSLATIONAL MEDICINE

JOHN WILEY & SONS LTD

1. Chinese National Natural Science Foundation [81602005, 81872499, 81772476] Funding Source: Medline
2. Science and Technology Program of Guangdong [2017B020227001] Funding Source: Medline
3. National Key R&D Program of China [2016YFC0905503, 2016YFC0905500] Funding Source: Medline
4. Central Basic Scientific Research Fund for Colleges-Young Teacher Training Program of Sun Yat-sen University [17ykpy81] Funding Source: Medline
5. Outstanding Young Talents Program of Sun Yat-sen University Cancer Center [16zxyc04] Funding Source: Medline